ARCHIVES

Study Recommends Longer Courses Of Chemotherapy For Bone Marrow Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 3 | March 31, 2006

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI Recieves Two Proposals For Antineoplaston Trials, None For Children; Stubble Elected To NAS

June 19, 1992

FDA’s Jane Henney

February 11, 1994

Bailer NEJM “Irresponsible, Purposely Misleading,” Ignored Facts, DeVita Tells NCA

May 23, 1986

Aflibercept-Docetaxel Combination Misses Primary Survival Endpoint

March 25, 2011

AACI, SCO, ACCC Hold Meeting With HCFA On DRG Issue

June 17, 1983

ODAC Says Clear Clinical Benefit Required When Sponsors Claim Progression Delay

July 17, 2009